Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
Go back to Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions| ATA, Inc. (NASDAQ: ATAI) | Delayed: 7.35 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.35 | 52 Week High | $7.32 | |||
| Open | $7.35 | 52 Week Low | $3.30 | |||
| Day High | $7.35 | P/E | N/A | |||
| Day Low | $7.35 | EPS | $0.00 | |||
| Volume | 40,000 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1183.46 +1.57 (0.13%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1181.89 | 52 Week High | $88.16 | |||
| Open | $1185.32 | 52 Week Low | $67.88 | |||
| Day High | $1190.00 | P/E | 273.95 | |||
| Day Low | $1160.84 | EPS | $4.32 | |||
| Volume | 1,924,379 | |||||
